About Visterra, Inc. (adapted from Visterra, Inc. prospectus):
They are a clinical-stage biopharmaceutical company focused on applying their novel Hierotope platform to identify unique disease targets and to design and engineer innovative antibody-based therapies that are intended to be effective as a single-dose administration.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.